“Key findings: The IP administration of BCA significantly decreased serum levels of urea, creatinine, uric acid and MDA and significantly increased serum CAT, GSH and TAC and cutaneous IL‐4 and GATA3 concentrations in the fifth and sixth groups compared to OVX‐DMSO and OVX‐ANA groups, respectively.”